Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy | |
Lin, Ying-Li; Deng, Qiu-Kui; Wang, Yu-Hao; Fu, Xing-Li; Ma, Jian-Guo; Li, Wen-Ping | |
刊名 | MEDICAL SCIENCE MONITOR |
2015 | |
卷号 | 21页码:3955-3960 |
关键词 | Biological Markers DNA Methylation Prostatic Neoplasms |
DOI | 10.12659/MSM.896763 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4767077 |
专题 | 山东大学 |
作者单位 | 1.Jiangsu Univ, Dept Urol, Xuzhou Canc Hosp, Affiliated Xuzhou Hosp, Xuzhou, Jiangsu, Peoples R China. 2.Shandong Univ, |
推荐引用方式 GB/T 7714 | Lin, Ying-Li,Deng, Qiu-Kui,Wang, Yu-Hao,et al. Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy[J]. MEDICAL SCIENCE MONITOR,2015,21:3955-3960. |
APA | Lin, Ying-Li,Deng, Qiu-Kui,Wang, Yu-Hao,Fu, Xing-Li,Ma, Jian-Guo,&Li, Wen-Ping.(2015).Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy.MEDICAL SCIENCE MONITOR,21,3955-3960. |
MLA | Lin, Ying-Li,et al."Aberrant Protocadherin17 (PCDH17) Methylation in Serum is a Potential Predictor for Recurrence of Early-Stage Prostate Cancer Patients After Radical Prostatectomy".MEDICAL SCIENCE MONITOR 21(2015):3955-3960. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论